ML239
-
Catalog number2696-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_nameN'-[(Z)-pyrrol-2-ylidenemethyl]-2-(2,4,6-trichlorophenoxy)acetohydrazide; (2,4,6-Trichlorophenoxy)-acetic acid (1H-pyrrol-2-ylmethylene)-hydrazide; CID-49843203
-
DescriptionML239 is a selective inhibitor of breast cancer stem cells. It inhibits cancer stem cells with an IC₅₀ of 1.16 μM with 24-fold selectivity against the control cell line. ML239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cytokine pathways.
-
CAS Number1378872-36-6
-
Structure AvailableY
-
Salt FormNo
-
Molecular FormulaC₁₃H10Cl₃N₃O₂
-
Molecular Weight346.6
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~15 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA selective inhibitor of breast cancer stem cell
-
Storage Condition-20°C
-
Shipping ConditionGel pack
-
Shelf Life36 months
-
MDL NumberMFCD23098913
-
PubChem CID49843203
-
SMILESC1=CC(=CNNC(=O)COC2=C(C=C(C=C2Cl)Cl)Cl)N=C1
-
InChiInChI=1S/C13H10Cl3N3O2/c14-8-4-10(15)13(11(16)5-8)21-7-12(20)19-18-6-9-2-1-3-17-9/h1-6,18H,7H2,(H,19,20)/b9-6-
-
InChi KeySZYDKEIZVCSYNB-TWGQIWQCSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameML239
-
Alternative nameML239
-